BIO vs. ZBH
BIO (Bio-Rad Laboratories, Inc.) and ZBH (Zimmer Biomet Holdings, Inc.) are both stocks. Both operate in the Medical Devices industry within the Healthcare sector. Over the past 10 years, BIO returned 8.34%/yr vs -2.15%/yr for ZBH. Their 0.37 correlation means their historical movements had little consistent relationship.
Performance
BIO vs. ZBH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BIO achieves a 7.42% return, which is significantly higher than ZBH's 5.02% return. Over the past 10 years, BIO has outperformed ZBH with an annualized return of 8.34%, while ZBH has yielded a comparatively lower -2.15% annualized return.
BIO
- 1D
- -0.38%
- 1M
- 9.64%
- 6M
- 10.82%
- YTD
- 7.42%
- 1Y
- 14.36%
- 3Y*
- -7.20%
- 5Y*
- -15.14%
- 10Y*
- 8.34%
- ALL TIME*
- 9.37%
ZBH
- 1D
- -1.08%
- 1M
- 7.39%
- 6M
- 8.46%
- YTD
- 5.02%
- 1Y
- 4.74%
- 3Y*
- -9.95%
- 5Y*
- -9.17%
- 10Y*
- -2.15%
- ALL TIME*
- 5.39%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $108.65M | $93.16M | $109.24M | |
| $205.34M | $207.14M | $199.64M |
BIO vs. ZBH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BIO Bio-Rad Laboratories, Inc. | 7.42% | -7.77% | 1.74% | -23.21% | -44.35% | 29.61% | 57.54% | 59.34% | -2.70% | 30.94% |
ZBH Zimmer Biomet Holdings, Inc. | 5.02% | -14.03% | -12.46% | -3.81% | 4.24% | -17.02% | 3.77% | 45.37% | -13.30% | 17.86% |
Correlation
The correlation between BIO and ZBH is 0.31, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.31 |
Correlation (3Y) Balances recent behavior with more history. | 0.31 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.35 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.35 |
Correlation (All Time) Calculated using the full available price history since Jul 25, 2001 | 0.37 |
Fundamentals
BIO:
$8.80B
ZBH:
$18.17B
BIO:
$6.26
ZBH:
$3.85
BIO:
51.99
ZBH:
24.38
BIO:
0.48
ZBH:
0.36
BIO:
3.39
ZBH:
2.21
BIO:
1.28
ZBH:
1.25
BIO:
$2.59B
ZBH:
$8.41B
BIO:
$1.34B
ZBH:
$5.89B
BIO:
$746.20M
ZBH:
$2.21B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BIO vs. ZBH — Risk / Return Rank
BIO
ZBH
BIO vs. ZBH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Bio-Rad Laboratories, Inc. (BIO) and Zimmer Biomet Holdings, Inc. (ZBH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BIO | ZBH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.72 | ||
| Sortino ratioReturn per unit of downside risk | +1.17 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.05 | +0.14 |
| Calmar ratioReturn relative to maximum drawdown | 1.20 | 0.14 | +1.06 |
| Martin ratioReturn relative to average drawdown | 2.67 | 0.25 | +2.42 |
Loading charts...
Drawdowns
BIO vs. ZBH - Drawdown Comparison
The maximum BIO drawdown since its inception was -83.64%, which is greater than ZBH's maximum drawdown of -65.03%. Use the drawdown chart below to compare losses from any high point for BIO and ZBH.
Loading charts...
Drawdown Indicators
| BIO | ZBH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.64% | -65.03% | -18.61% |
Max Drawdown (1Y)Largest decline over 1 year | -28.86% | -25.54% | -3.32% |
Max Drawdown (3Y)Largest decline over 3 years | -46.24% | -38.82% | -7.42% |
Max Drawdown (5Y)Largest decline over 5 years | -73.77% | -43.94% | -29.83% |
Max Drawdown (10Y)Largest decline over 10 years | -73.77% | -52.14% | -21.63% |
Current DrawdownCurrent decline from peak | -60.58% | -43.35% | -17.23% |
Average DrawdownAverage peak-to-trough decline | -27.85% | -20.21% | -7.64% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.97% | 14.17% | -1.20% |
Volatility
BIO vs. ZBH - Volatility Comparison
The current volatility for Bio-Rad Laboratories, Inc. (BIO) is 8.54%, while Zimmer Biomet Holdings, Inc. (ZBH) has a volatility of 10.54%. This indicates that BIO experiences smaller price fluctuations and is considered to be less risky than ZBH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BIO | ZBH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.54% | 10.54% | -2.00% |
Volatility (6M)Calculated over the trailing 6-month period | 30.08% | 23.22% | +6.86% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.91% | 32.47% | +9.44% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 37.59% | 27.10% | +10.49% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.23% | 28.66% | +5.57% |
Dividends
BIO vs. ZBH - Dividend Comparison
BIO has not paid dividends to shareholders, while ZBH's dividend yield for the trailing twelve months is around 1.02%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BIO Bio-Rad Laboratories, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ZBH Zimmer Biomet Holdings, Inc. | 1.02% | 1.07% | 0.91% | 0.79% | 0.75% | 0.76% | 0.62% | 0.64% | 0.93% | 0.80% | 0.93% | 0.86% |
Financials
BIO vs. ZBH - Financials Comparison
This section allows you to compare key financial metrics between Bio-Rad Laboratories, Inc. and Zimmer Biomet Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BIO vs. ZBH - Profitability Comparison
BIO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Bio-Rad Laboratories, Inc. reported a gross profit of 309.40M and revenue of 592.10M. Therefore, the gross margin over that period was 52.3%.
ZBH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Zimmer Biomet Holdings, Inc. reported a gross profit of 1.51B and revenue of 2.09B. Therefore, the gross margin over that period was 72.4%.
BIO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Bio-Rad Laboratories, Inc. reported an operating income of 34.10M and revenue of 592.10M, resulting in an operating margin of 5.8%.
ZBH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Zimmer Biomet Holdings, Inc. reported an operating income of 373.20M and revenue of 2.09B, resulting in an operating margin of 17.9%.
BIO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Bio-Rad Laboratories, Inc. reported a net income of -527.10M and revenue of 592.10M, resulting in a net margin of -89.0%.
ZBH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Zimmer Biomet Holdings, Inc. reported a net income of 238.10M and revenue of 2.09B, resulting in a net margin of 11.4%.
Frequently Asked Questions
BIO and ZBH have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ZBH has higher volatility (10.54%) compared to BIO (8.54%). In terms of maximum drawdown, BIO dropped -83.64% vs ZBH's -65.03%.
BIO currently has the higher Sharpe Ratio (0.83 vs 0.11), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BIO and ZBH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer